After the great recession of 2007, it wasn’t until 2013 that the U.S. medical device business showed improving revenue trends. The momentum created by Obamacare (20 million more patients, yes!) drove growth in hospital admissions and other systems of healthcare utilization that didn’t exist before 2010.
It is all about medtech strategy. Innumerable billion-dollar investments from U.S. government financing of the Precision Medicine program, notable product launches, and significant clinical data is the much-to-admire status of the diagnostics industry.